Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 02 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated July 02, 2021, titled "Zydus Cadila receives final approval from USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases